Valeant Pharma (VRX) Bounces Modestly Off Lows Following Ackman Letter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
March 15, 2016 3:58 PM EDTPershing Square's Bill Ackman is adding to his stake in Valeant Pharma (NYSE: VRX) amid today's sell-off, according to unconfirmed market chatter.... More
Deutsche Bank Comments on Valeant Pharma (VRX) Following Q4 Call
March 15, 2016 2:20 PM EDTDeutsche Bank analyst Gregg Gilbert commented on Valeant Pharma (NYSE: VRX) after it released Q4 earnings and discussed challenges on its conference call. The analyst noted operational challenges and overhang from its 10-K delay.
"The new 2016 guidance reflects in large part lower growth assumptions for the core US business (including Dermatology and GI) without offsetting cost reductions (which the company will explore). On the positive side, VRX described making progress with payors, and cited greater visibility on managed... More
Ackman's Pershing Square Sends Letter to Investors Following Valeant's (VRX) Q4 Report, Updated Outlook
March 15, 2016 12:15 PM EDTRegulatory News:
Pershing Square Holdings, Ltd. today released an email to investors. The text of the email is set forth below:
Dear Pershing Square Investor,
Today, Valeant (NYSE: VRX) reported preliminary unaudited earnings for Q4, updated guidance for Q1, full year 2016 and the next twelve months. In particular, management shocked the market with revenue and earnings... More
